End-of-day quote
Shanghai S.E.
06:00:00 2024-04-25 pm EDT
|
5-day change
|
1st Jan Change
|
42.04
CNY
|
+3.80%
|
|
-1.73%
|
-8.33%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
3,912
|
7,098
|
10,217
|
40,129
|
18,707
|
9,295
|
Enterprise Value (EV)
1 |
3,802
|
7,318
|
9,772
|
39,214
|
17,781
|
9,690
|
P/E ratio
|
19.1
x
|
23
x
|
39.4
x
|
34.1
x
|
21
x
|
510
x
|
Yield
|
3.11%
|
-
|
1.19%
|
-
|
0.33%
|
-
|
Capitalization / Revenue
|
0.73
x
|
1.53
x
|
2.28
x
|
5.69
x
|
2.25
x
|
1.65
x
|
EV / Revenue
|
0.71
x
|
1.58
x
|
2.18
x
|
5.56
x
|
2.14
x
|
1.72
x
|
EV / EBITDA
|
7.72
x
|
13.6
x
|
17.3
x
|
22.7
x
|
16.6
x
|
55.2
x
|
EV / FCF
|
7.63
x
|
85.2
x
|
20.6
x
|
103
x
|
38.4
x
|
76.1
x
|
FCF Yield
|
13.1%
|
1.17%
|
4.84%
|
0.97%
|
2.61%
|
1.31%
|
Price to Book
|
2.42
x
|
3.93
x
|
4.96
x
|
13
x
|
4.75
x
|
2.72
x
|
Nbr of stocks (in thousands)
|
202,680
|
202,680
|
202,680
|
202,680
|
202,680
|
202,680
|
Reference price
2 |
19.30
|
35.02
|
50.41
|
198.0
|
92.30
|
45.86
|
Announcement Date
|
3/26/19
|
4/9/20
|
3/29/21
|
4/28/23
|
4/28/23
|
4/25/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
5,331
|
4,643
|
4,475
|
7,056
|
8,316
|
5,635
|
EBITDA
1 |
492.2
|
538.3
|
564.5
|
1,725
|
1,072
|
175.4
|
EBIT
1 |
319.7
|
359.4
|
389.9
|
1,558
|
904.1
|
-59.23
|
Operating Margin
|
6%
|
7.74%
|
8.71%
|
22.07%
|
10.87%
|
-1.05%
|
Earnings before Tax (EBT)
1 |
249.3
|
369.6
|
314.6
|
1,502
|
1,024
|
-76.54
|
Net income
1 |
205.4
|
308.5
|
259.8
|
1,178
|
890.5
|
18.73
|
Net margin
|
3.85%
|
6.64%
|
5.81%
|
16.7%
|
10.71%
|
0.33%
|
EPS
2 |
1.010
|
1.520
|
1.280
|
5.810
|
4.390
|
0.0900
|
Free Cash Flow
1 |
498.1
|
85.87
|
473.3
|
379.3
|
463.4
|
127.3
|
FCF margin
|
9.34%
|
1.85%
|
10.58%
|
5.38%
|
5.57%
|
2.26%
|
FCF Conversion (EBITDA)
|
101.2%
|
15.95%
|
83.84%
|
21.99%
|
43.24%
|
72.54%
|
FCF Conversion (Net income)
|
242.53%
|
27.84%
|
182.18%
|
32.19%
|
52.04%
|
679.57%
|
Dividend per Share
2 |
0.6000
|
-
|
0.6000
|
-
|
0.3000
|
-
|
Announcement Date
|
3/26/19
|
4/9/20
|
3/29/21
|
4/28/23
|
4/28/23
|
4/25/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
220
|
-
|
-
|
-
|
395
|
Net Cash position
1 |
110
|
-
|
445
|
915
|
926
|
-
|
Leverage (Debt/EBITDA)
|
-
|
0.4092
x
|
-
|
-
|
-
|
2.25
x
|
Free Cash Flow
1 |
498
|
85.9
|
473
|
379
|
463
|
127
|
ROE (net income / shareholders' equity)
|
12.1%
|
18%
|
12.2%
|
44.3%
|
22.1%
|
-1.42%
|
ROA (Net income/ Total Assets)
|
7.38%
|
7.47%
|
7.48%
|
24.4%
|
10.2%
|
-0.54%
|
Assets
1 |
2,783
|
4,129
|
3,475
|
4,823
|
8,743
|
-3,461
|
Book Value Per Share
2 |
7.970
|
8.920
|
10.20
|
15.30
|
19.40
|
16.90
|
Cash Flow per Share
2 |
0.7600
|
1.530
|
2.860
|
4.260
|
6.050
|
2.800
|
Capex
1 |
55.1
|
83.5
|
237
|
424
|
720
|
817
|
Capex / Sales
|
1.03%
|
1.8%
|
5.29%
|
6.01%
|
8.66%
|
14.5%
|
Announcement Date
|
3/26/19
|
4/9/20
|
3/29/21
|
4/28/23
|
4/28/23
|
4/25/24
|
|
1st Jan change
|
Capi.
|
---|
| -8.33% | 1.18B | | +5.14% | 103B | | -5.63% | 63.04B | | +39.52% | 39.06B | | +12.91% | 37.58B | | +7.41% | 33.24B | | +6.85% | 19.22B | | +12.86% | 16.83B | | +7.73% | 15.03B | | +16.93% | 14.96B |
Other Commodity Chemicals
|